Browse the corpus

Walk the evidence base by book and chapter — the raw source passages that ground Ask, Differential, and the rest.

• Anti-influenza hyperimmune intravenous immunoglobulin for adults with influenza A or B infection (FLU-IVIG): a double-blind, randomised, placebo-controlled trial Davey50 passages
• Assessment of Mycobacterium tuberculosis transmission in Oxfordshire, UK, 2007–12, with whole pathogen genome sequences: an observational study Walker28 passages
• Bubble continuous positive airway pressure for children with high-risk conditions and severe pneumonia in Malawi: an open label, randomised, controlled trial McCollum44 passages
• Centre, Nuffield Department of Population Health, University of Oxford, Oxford, UKc Department of Computer Science, University of Oxford, Oxford, UKd Brighton and Sussex University37 passages
• Centre, University of Oxford, Oxford, UKn42 passages
• Council and KwaZulu Research Institute for TB and HIV, Durban, South Africae Institute of Respiratory Medicine, Kuala Lumpur, Malaysiaf Chest Disease Institute, Muang, Nothaburi, Thailandg25 passages
• Deep learning and the evaluation of pulmonary fibrosis Levin5 passages
• Diagnostic accuracy of whole-body MRI versus standard imaging pathways for metastatic disease in newly diagnosed non-small-cell lung cancer: the prospective38 passages
• Effects of saline or albumin fluid bolus in resuscitation: evidence from re-analysis of the FEAST trial Levin Michael ProfFMedScim.levin@imperial.ac.uka†*Cunnington53 passages
• Frequency of Exacerbations in COPD: An Analysis of the SPIROMICS Cohort Han MeiLan K. MD1Quibrera37 passages
• Genetic determinants of risk in pulmonary arterial hypertension: international genome-wide association studies and meta-analysis Rhodes43 passages
• Genetic variants associated with susceptibility to idiopathic pulmonary fibrosis in people of European ancestry: a genome-wide association study Allen39 passages
• Group, Centre for Medical Informatics, Usher Institute of Population Health Sciences and Informatics, University of Edinburgh, Edinburgh, UKd Cancer34 passages
• Increased monocyte count as a cellular biomarker for poor outcomes in fibrotic diseases: a retrospective, multicentre cohort study Scott40 passages
• Institute, Barts and The London School of Medicine, Queen Mary University, London, UK* Correspondence to: Prof44 passages
• Lancet Respir Med712 passages
• Moderate-to-severe asthma in individuals of European ancestry: a genome-wide association study Shrine Nick PhDa†Portelli49 passages
• Mortality, morbidity, and hospitalisations due to influenza lower respiratory tract infections, 2017: an analysis for the Global Burden of Disease Study 2017 GBD 2017 Influenza CollaboratorsTroeger63 passages
• Mycophenolate Mofetil versus Oral Cyclophosphamide in Scleroderma-related Interstitial Lung Disease: Scleroderma Lung53 passages
• Pulmonary artery enlargement and cystic fibrosis pulmonary exacerbations: a cohort study33 passages
• Sputum or blood eosinophil association with clinical measures of COPD severity in the SPIROMICS cohort42 passages
• Susceptibility to corticosteroid-induced adrenal suppression: a genome-wide association study Hawcutt33 passages
• The MUC5B promoter polymorphism and telomere length in patients with chronic hypersensitivity pneumonitis Ley Brett MD1*Newton37 passages
• The burden of transmitted multi-drug resistance among epidemics of tuberculosis: A transmission model Kendall30 passages
• Unit, Glenfield Hospital, Leicester, UK* Correspondence to: Prof46 passages
• Validating a 52-gene risk profile for outcome prediction in Idiopathic Pulmonary Fibrosis: an international multicentre cohort study Herazo-Maya35 passages